Timothy Murphy is a Director; Preclinical Research at NeoSome Life Sciences, LLC at NeoSome Life Sciences, LLC. He possess expertise in drug discovery, in vivo, infectious diseases, in vitro, microbiology and 1 more skills. Colleagues describe him as "I had the opportunity to work with Tim for several years at Wyeth when he was a part of my group in Infectious Disease. Tim is an extremely intelligent individual and made major contributions to the discovery and development programs at Wyeth in both antibacterial and antiviral discovery programs. He was an integral part of the in vivo evaluation for tigecycline (Tygacil) and the resulting development to a clinical candidate. He has an excellent work ethic, being very deliberate and exacting in his approach, fully interrogating both the experimental design and resulting data. Tim has a strong and solid background in infectious disease models and draws on this experience to continue to assist others in advancing potential molecules from discovery to lead selection and development."